Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Watertown, Massachusetts
- Most recent report
- 8-K, filed Sep 10, 2026
- Filings on record
- 757 filings
- On EDGAR
- CIK 1816736
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 24
News 8 of 94
- 8-K Other events Sep 10, 2026
- 8-K Quarterly results Jul 30, 2026
- 8-K Significant contract Jun 30, 2026
- 8-K Shareholder vote results Jun 24, 2026
- 8-K Quarterly results May 5, 2026
- 8-K Current report on a material event Feb 27, 2026
- 8-K Quarterly results Feb 26, 2026
- 8-K Current report on a material event Feb 17, 2026
Prospectuses and Registrations 8 of 59
- S-8 Registration statement for an employee plan Feb 26, 2026
- 424B5 Prospectus supplement for an offering Oct 21, 2025
- 424B5 Prospectus supplement for an offering Oct 20, 2025
- S-8 Registration statement for an employee plan Feb 27, 2025
- 424B5 Prospectus supplement for an offering Jan 23, 2025
- 424B5 Prospectus supplement for an offering Jan 21, 2025
- 424B5 Prospectus supplement for an offering Nov 15, 2024
- POS AM Post-effective amendment to a registration Nov 15, 2024
Proxies 8 of 10
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEFA14A Extra proxy material Apr 24, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2025
- DEF 14A Proxy statement for a shareholder vote May 1, 2024
- DEFA14A Extra proxy material May 1, 2024
- DEFA14A Extra proxy material Apr 20, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 20, 2023
Ownership 8 of 514
- 4 Insider reported a trade Sep 16, 2026
- 4 Insider reported a trade Sep 15, 2026
- 144 Notice of a proposed sale of restricted stock Sep 11, 2026
- 4 Insider reported a trade Sep 9, 2026
- 144 Notice of a proposed sale of restricted stock Sep 4, 2026
- 144 Notice of a proposed sale of restricted stock Sep 4, 2026
- 144 Notice of a proposed sale of restricted stock Sep 4, 2026
- 144 Notice of a proposed sale of restricted stock Sep 4, 2026
Other 8 of 56
- ARS Annual report sent to shareholders Apr 28, 2026
- ARS Annual report sent to shareholders Apr 24, 2025
- EFFECT Notice that a registration became effective Nov 19, 2024
- ARS Annual report sent to shareholders May 1, 2024
- EFFECT Notice that a registration became effective Dec 6, 2023
- EFFECT Notice that a registration became effective Nov 29, 2023
- CORRESP Reply to SEC staff Nov 27, 2023
- UPLOAD Comment letter from SEC staff Nov 27, 2023
Everything here comes from Disc Medicine, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.